Last update 19 Apr 2025

AL-001 (Anlong)

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
AL 001, AL-001, AL001
Target
VEGF
Action
inhibitors
Mechanism
VEGF inhibitors(Vascular endothelial growth factor inhibitors)
Therapeutic Areas
Congenital DisordersEye Diseases
Active Indication
Wet age-related macular degeneration
Inactive Indication-
Originator Organization
Beijing Anlong Biomedical Co., Ltd.Beijing Anlong Biomedical Co., Ltd.
Active Organization
Beijing Anlong Biomedical Co., Ltd.Beijing Anlong Biomedical Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with AL-001 (Anlong)
NCT06839339
/ Not yet recruitingPhase 2
A Phase II, Randomized, Positive-controlled, Multicenter Clinical Study to Evaluate the Efficacy and Safety of Single Suprachoroidal Space Injection of AL-001 Ophthalmic Injection in Subjects with Wet Age-related Macular Degeneration (wAMD)
CTR20231950
/ RecruitingPhase 1/2
一项评价AL-001眼用注射液在湿性年龄相关性黄斑变性（wAMD）患者中安全性和耐受性及药代动力学的开放性、非随机、单臂、单次给药、剂量递增的I/IIa期临床研究
[Translation] An open-label, non-randomized, single-arm, single-dose, dose-escalating Phase I/IIa clinical study to evaluate the safety, tolerability and pharmacokinetics of AL-001 ophthalmic injection in patients with wet age-related macular degeneration (wAMD)
NCT06707753
/ Active, not recruitingPhase 1/2
An Open-label, Nonrandomized, Single-arm, Single Dose, Dose-escalation Phase I/IIa Study to Evaluate the Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with Wet Age-related Macular Degeneration (wAMD)
100 Clinical Results associated with AL-001 (Anlong)
Login to view more data
100 Translational Medicine associated with AL-001 (Anlong)
Login to view more data
100 Patents (Medical) associated with AL-001 (Anlong)
Login to view more data
100 Deals associated with AL-001 (Anlong)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Wet age-related macular degenerationPhase 2
China
Beijing Anlong Biomedical Co., Ltd.Beijing Anlong Biomedical Co., Ltd.
18 Feb 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free